Peripheral Immune Remodeling After Spinal Cord Injury

Read full text
Authors: Naomi Veeningen, Ana Laura Añé-Kourí, A. Pues, Serina Rubio, Judith Fraussen, Charalampia Ioannou, Dries S. Martens, Charlotte C.M. van Laake-Geelen, Jens Deckers, Erwin M. J. Cornips, Sven Bamps, Griet Gysemberg
+3 more Jana Van Broeckhoven, Niels Hellings, Helena Slaets
Cited by: 1
References: 44

Abstract

BACKGROUND AND OBJECTIVES: Spinal cord injury (SCI) is associated with severe immunologic changes, such as SCI-induced immune deficiency syndrome, which heightens susceptibility to infections. However, the immune components underlying this immune reorganization remain poorly defined. This study aimed to characterize immune remodeling in patients with SCI across different time points postinjury. METHODS: High-dimensional flow cytometric profiling was performed on peripheral blood samples from patients with SCI in a cross-sectional observational study to assess immune changes at different postinjury time points. Patients in the subacute phase (22-67 days of postinjury [dpi]) and chronic phase (≥365 dpi) were compared with healthy, sex-matched, and age-matched controls. RESULTS: metabolizing enzyme CD38 and immune checkpoint molecules, cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed cell death protein 1 (PD-1), indicating immune activation and possible exhaustion. Coexpression of CD38 and CTLA-4 on T cells was rare, suggesting distinct activation and inhibitory states. In chronic patients, we observed decreased frequencies of NK cells with no substantial changes in T cells and B cells. Notably, changes in CD38, CTLA-4, and PD-1 were no longer found in patients in the chronic phase. DISCUSSION: metabolism and immune checkpoint modulation.

Fields of Study & Subjects

Spinal Cord Injury Research Nerve injury and regeneration Immune cells in cancer

Publication details

Journal / source
Neurology Neuroimmunology & Neuroinflammation
Publisher
Ovid Technologies (Wolters Kluwer Health)
Volume
13
Issue
2
Pages
e200544–e200544
Publication date
28 January 2026
Language
EN